{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T11:17:55Z","timestamp":1774523875658,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-04818-z","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T09:17:31Z","timestamp":1771492651000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hematologic response and kidney outcomes of monoclonal gammopathy of renal significance excluding AL amyloidosis: a report of six cases"],"prefix":"10.1186","volume":"27","author":[{"given":"Hiroki","family":"Nobayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Haruhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Shiina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Katsuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Okabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhito","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Yokoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"issue":"1","key":"4818_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41581-018-0077-4","volume":"15","author":"N Leung","year":"2019","unstructured":"Leung N, Bridoux F, Batuman V, Chaidos A, Cockwell P, D\u2019Agati VD, Dispenzieri A, Fervenza FC, Fermand JP, Gibbs S, et al. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the international kidney and monoclonal gammopathy research group. Nat Rev Nephrol. 2019;15(1):45\u201359.","journal-title":"Nat Rev Nephrol"},{"issue":"20","key":"4818_CR2","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1056\/NEJMra1810907","volume":"384","author":"N Leung","year":"2021","unstructured":"Leung N, Bridoux F, Nasr SH. Monoclonal gammopathy of renal significance. N Engl J Med. 2021;384(20):1931\u201341.","journal-title":"N Engl J Med"},{"issue":"22","key":"4818_CR3","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1182\/blood-2013-05-495929","volume":"122","author":"JP Fermand","year":"2013","unstructured":"Fermand JP, Bridoux F, Kyle RA, Kastritis E, Weiss BM, Cook MA, Drayson MT, Dispenzieri A, Leung N, International K, et al. How I treat monoclonal gammopathy of renal significance (MGRS). Blood. 2013;122(22):3583\u201390.","journal-title":"Blood"},{"issue":"1","key":"4818_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.kint.2018.02.020","volume":"94","author":"R Gumber","year":"2018","unstructured":"Gumber R, Cohen JB, Palmer MB, Kobrin SM, Vogl DT, Wasserstein AG, Nasta SD, Bleicher MB, Bloom RD, Dember L, et al. A clone-directed approach May improve diagnosis and treatment of proliferative glomerulonephritis with monoclonal Immunoglobulin deposits. Kidney Int. 2018;94(1):199\u2013205.","journal-title":"Kidney Int"},{"issue":"11","key":"4818_CR5","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1182\/blood-2016-08-737163","volume":"129","author":"S Chauvet","year":"2017","unstructured":"Chauvet S, Fremeaux-Bacchi V, Petitprez F, Karras A, Daniel L, Burtey S, Choukroun G, Delmas Y, Guerrot D, Francois A, et al. Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy. Blood. 2017;129(11):1437\u201347.","journal-title":"Blood"},{"key":"4818_CR6","doi-asserted-by":"crossref","unstructured":"Granina E, Henderson J, Bertrand KA, Sanchorawala V, Szalat RE. Epidemiological characteristics and clinical outcomes of patients with monoclonal gammopathy of renal significance (MGRS) diagnosed in a large safety-net hospital in the US. Blood. 2024;144(Supplement 1):4680-4680.","DOI":"10.1182\/blood-2024-206486"},{"issue":"1","key":"4818_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1056\/NEJMoa2028631","volume":"385","author":"E Kastritis","year":"2021","unstructured":"Kastritis E, Palladini G, Minnema MC, Wechalekar AD, Jaccard A, Lee HC, Sanchorawala V, Gibbs S, Mollee P, Venner CP, et al. Daratumumab-Based treatment for Immunoglobulin Light-Chain amyloidosis. N Engl J Med. 2021;385(1):46\u201358.","journal-title":"N Engl J Med"},{"issue":"1","key":"4818_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/bjh.17052","volume":"193","author":"E Kastritis","year":"2021","unstructured":"Kastritis E, Theodorakakou F, Roussou M, Psimenou E, Gakiopoulou C, Marinaki S, Gatou A, Fotiou D, Migkou M, Kanellias N, et al. Daratumumab-based therapy for patients with monoclonal gammopathy of renal significance. Br J Haematol. 2021;193(1):113\u20138.","journal-title":"Br J Haematol"},{"issue":"36","key":"4818_CR9","doi-asserted-by":"publisher","first-page":"4541","DOI":"10.1200\/JCO.2011.37.7614","volume":"30","author":"G Palladini","year":"2012","unstructured":"Palladini G, Dispenzieri A, Gertz MA, Kumar S, Wechalekar A, Hawkins PN, Schonland S, Hegenbart U, Comenzo R, Kastritis E, et al. New criteria for response to treatment in Immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes. J Clin Oncol. 2012;30(36):4541\u20139.","journal-title":"J Clin Oncol"},{"issue":"5","key":"4818_CR10","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1182\/blood-2017-02-767475","volume":"130","author":"T Dittrich","year":"2017","unstructured":"Dittrich T, Bochtler T, Kimmich C, Becker N, Jauch A, Goldschmidt H, Ho AD, Hegenbart U, Schonland SO. AL amyloidosis patients with low amyloidogenic free light chain levels at first diagnosis have an excellent prognosis. Blood. 2017;130(5):632\u201342.","journal-title":"Blood"},{"issue":"5","key":"4818_CR11","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1182\/blood-2017-02-767467","volume":"130","author":"P Milani","year":"2017","unstructured":"Milani P, Basset M, Russo F, Foli A, Merlini G, Palladini G. Patients with light-chain amyloidosis and low free light-chain burden have distinct clinical features and outcome. Blood. 2017;130(5):625\u201331.","journal-title":"Blood"},{"issue":"2","key":"4818_CR12","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.kint.2025.04.007","volume":"108","author":"SH Nasr","year":"2025","unstructured":"Nasr SH, Royal V, Best Rocha A, Buttner-Herold M, Roufosse C, Bridoux F, Ismail W, Bu L, Cornell LD, Dendooven A, et al. Renal pathology Society\/International kidney and monoclonal gammopathy research group consensus on pathologic definitions and terminology of monoclonal gammopathy-associated kidney lesions. Kidney Int. 2025;108(2):184\u201393.","journal-title":"Kidney Int"},{"issue":"1","key":"4818_CR13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/ndt\/gfae224","volume":"40","author":"S Anand","year":"2024","unstructured":"Anand S, O\u2019Neill-Dee M, Sanchorawala V, Verma A. Light-chain (AL) amyloidosis for nephrologists-treatment standard. Nephrol Dial Transpl. 2024;40(1):34\u201347.","journal-title":"Nephrol Dial Transpl"},{"issue":"5","key":"4818_CR14","doi-asserted-by":"publisher","first-page":"100617","DOI":"10.1016\/j.xkme.2023.100617","volume":"5","author":"A Katsuma","year":"2023","unstructured":"Katsuma A, Okabe M, Ueda H, Ehara T, Yamaguchi Y, Miyazaki Y, Yokoo T. Histiocytic glomerulopathy with noncrystalline inclusion associated with IgG-Kappa plasma cell dyscrasia. Kidney Med. 2023;5(5):100617.","journal-title":"Kidney Med"},{"issue":"4","key":"4818_CR15","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1053\/j.ajkd.2024.03.021","volume":"84","author":"Y Wang","year":"2024","unstructured":"Wang Y, Chen D, Hu R, Zhang Y, Liang D, Xu F, Liu F, Zhu X, Lin Y, Yang X, et al. Clinicopathological characteristics of light and heavy chain deposition disease: A case series. Am J Kidney Dis. 2024;84(4):447\u2013e456441.","journal-title":"Am J Kidney Dis"},{"issue":"26","key":"4818_CR16","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1182\/blood-2015-07-658872","volume":"126","author":"RH Sayed","year":"2015","unstructured":"Sayed RH, Wechalekar AD, Gilbertson JA, Bass P, Mahmood S, Sachchithanantham S, Fontana M, Patel K, Whelan CJ, Lachmann HJ, et al. Natural history and outcome of light chain deposition disease. Blood. 2015;126(26):2805\u201310.","journal-title":"Blood"},{"issue":"3","key":"4818_CR17","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/ajh.26801","volume":"98","author":"MJ Pianko","year":"2023","unstructured":"Pianko MJ, Tiutan T, Derkach A, Flynn J, Salvatore SP, Jaffer-Sathick I, Rossi AC, Lahoud O, Hultcrantz M, Shah UA, et al. Assessment of renal outcome following therapy in monoclonal Immunoglobulin deposition disease: emphasizing the need for a consensus approach. Am J Hematol. 2023;98(3):421\u201331.","journal-title":"Am J Hematol"},{"key":"4818_CR18","doi-asserted-by":"crossref","unstructured":"Mancuso K, Mina R, Rocchi S, Antonioli E, Petrucci MT, Fazio F, Gozzetti A, Salvini M, Cartia CS, Bertuglia G, et al. Clinical presentation and long-term survival outcomes of patients with monoclonal gammopathy of renal significance (MGRS): a multicenter retrospective study. Cancer Med. 2024;13(22).","DOI":"10.1002\/cam4.70266"},{"issue":"2","key":"4818_CR19","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.kint.2024.02.027","volume":"106","author":"SH Nasr","year":"2024","unstructured":"Nasr SH, Sirac C, Leung N, Bridoux F. Monoclonal Immunoglobulin crystalline nephropathies. Kidney Int. 2024;106(2):201\u201313.","journal-title":"Kidney Int"},{"issue":"4","key":"4818_CR20","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1111\/bjh.17412","volume":"193","author":"A Kuzume","year":"2021","unstructured":"Kuzume A, Tabata R, Terao T, Tsushima T, Miura D, Narita K, Takeuchi M, Matsue K. Safety and efficacy of daratumumab in patients with multiple myeloma and severe renal failure. Br J Haematol. 2021;193(4):e33\u20136.","journal-title":"Br J Haematol"},{"issue":"2","key":"4818_CR21","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1053\/j.ajkd.2021.04.015","volume":"79","author":"C Heybeli","year":"2022","unstructured":"Heybeli C, Alexander MP, Bentall AJ, Amer H, Buadi FK, Dean PG, Dingli D, Dispenzieri A, El Ters M, Gertz MA, et al. Kidney transplantation in patients with monoclonal gammopathy of renal significance (MGRS)-Associated lesions: A case series. Am J Kidney Dis. 2022;79(2):202\u201316.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"4818_CR22","doi-asserted-by":"publisher","first-page":"151497","DOI":"10.1016\/j.semnephrol.2024.151497","volume":"44","author":"N Leung","year":"2024","unstructured":"Leung N, Heybeli C. Kidney transplantation in multiple myeloma and monoclonal gammopathy of renal significance. Semin Nephrol. 2024;44(1):151497.","journal-title":"Semin Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-04818-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04818-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04818-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T10:42:19Z","timestamp":1774521739000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-04818-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4818"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-04818-z","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"3 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This case report was prepared as part of a study titled \u201cInvestigation of Treatment and Prognosis of Monoclonal Gammopathy of Renal Significance,\u201d approved by the Ethics Committee of Jikei University School of Medicine (approval no: 36\u2013148[12257]). The study was performed in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The requirement for informed consent from the patients was waived because of the retrospective nature of the study. Instead, all individual participants were provided the opportunity to opt out of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for the publication of this case report. In cases where written informed consent could not be obtained directly, the study details were explained, and the obtained consent was documented in the electronic medical record.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"187"}}